Search

Your search keyword '"Rockhold, Frank"' showing total 575 results

Search Constraints

Start Over You searched for: Author "Rockhold, Frank" Remove constraint Author: "Rockhold, Frank"
575 results on '"Rockhold, Frank"'

Search Results

1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

2. Framework of the strengths and challenges of clinically integrated trials: An expert panel report

4. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

6. Comparing Ways to Decrease Severe Asthma Attacks among Black and Latinx Adults with Moderate to Severe Asthma -- The PREPARE Study

7. Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD

10. Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial

12. Myocardial Infarction in the ISCHEMIA Trial

13. Impact of Complete Revascularization in the ISCHEMIA Trial

14. Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial

17. Comparative Prognostic Utility of Coronary CT and Invasive Angiography

19. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

20. Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions — proceedings from the CEC Summit 2018

21. Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

23. Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

24. The Case for Access to Data Monitoring Committee Charters.

25. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy

29. Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages

31. Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting

33. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

34. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

38. Ferric Carboxymaltose in Heart Failure with Iron Deficiency

43. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial

45. A Framework for Safety Evaluation Throughout the Product Development Life-Cycle

46. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

Catalog

Books, media, physical & digital resources